Suppr超能文献

相似文献

1
Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.
Oncologist. 2016 May;21(5):576-85. doi: 10.1634/theoncologist.2015-0393. Epub 2016 Mar 29.
3
Bevacizumab for the treatment of cervical cancer.
Expert Opin Biol Ther. 2016;16(3):407-19. doi: 10.1517/14712598.2016.1145208.
4
Integration of bevacizumab with chemotherapy doublets for advanced cervical cancer.
Expert Opin Pharmacother. 2015 Apr;16(5):675-83. doi: 10.1517/14656566.2015.1010511. Epub 2015 Feb 3.
5
Changing paradigms in the systemic treatment of advanced cervical cancer.
Am J Obstet Gynecol. 2016 Jan;214(1):22-30. doi: 10.1016/j.ajog.2015.07.022. Epub 2015 Jul 26.
6
Targeted Agents in Cervical Cancer: Beyond Bevacizumab.
Curr Oncol Rep. 2018 Apr 2;20(5):40. doi: 10.1007/s11912-018-0680-3.
7
[Not Available].
Bull Cancer. 2017 May;104 Suppl 1:S39-S42. doi: 10.1016/S0007-4551(17)30161-3.
8
Bevacizumab in Cervical Cancer: 5 Years After.
Cancer J. 2018 Jul/Aug;24(4):187-192. doi: 10.1097/PPO.0000000000000324.
10
Anti-angiogenesis agents in metastatic or recurrent cervical cancer.
Gynecol Oncol. 2010 Feb;116(2):181-6. doi: 10.1016/j.ygyno.2009.09.033. Epub 2009 Oct 27.

引用本文的文献

2
Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer.
Med Oncol. 2024 Jul 10;41(8):199. doi: 10.1007/s12032-024-02446-x.
3
Clinical Application of Small Extracellular Vesicles in Gynecologic Malignancy Treatments.
Cancers (Basel). 2023 Mar 26;15(7):1984. doi: 10.3390/cancers15071984.
5
Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis.
Front Immunol. 2022 Dec 9;13:966291. doi: 10.3389/fimmu.2022.966291. eCollection 2022.
6
Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells.
Front Immunol. 2022 Oct 21;13:918528. doi: 10.3389/fimmu.2022.918528. eCollection 2022.
10
Assessment of Hypoxic Tissue Fraction and Prediction of Survival in Cervical Carcinoma by Dynamic Contrast-Enhanced MRI.
Front Oncol. 2021 May 20;11:668916. doi: 10.3389/fonc.2021.668916. eCollection 2021.

本文引用的文献

1
Cancer statistics, 2016.
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30. doi: 10.3322/caac.21332. Epub 2016 Jan 7.
2
The roles and clinical significance of microRNAs in cervical cancer.
Histol Histopathol. 2016 Feb;31(2):131-9. Epub 2015 Sep 10.
5
Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.
PLoS One. 2015 Jun 12;10(6):e0129119. doi: 10.1371/journal.pone.0129119. eCollection 2015.
7
The differential expression of OCT4 isoforms in cervical carcinoma.
PLoS One. 2015 Mar 27;10(3):e0118033. doi: 10.1371/journal.pone.0118033. eCollection 2015.
8
Cervical cancer: Biomarkers for diagnosis and treatment.
Clin Chim Acta. 2015 May 20;445:7-11. doi: 10.1016/j.cca.2015.03.005. Epub 2015 Mar 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验